Biomarker trajectory for earlier detection of lung cancer
Open Access
- 30 September 2024
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 108, 105377
Abstract
No abstract availableKeywords
Funding Information
- Center for Clinical and Translational Science, University of Illinois at Chicago (TR000371)
- National Cancer Institute (U24CA086368, P30CA016672, EDRN U01 CA200468)
- Cancer Prevention and Research Institute of Texas (P50CA140388, RP160693, RP180505)
- Lyda Hill Foundation
- National Institutes of Health (U01CA213285, U01CA194733, U01CA271888)
This publication has 29 references indexed in Scilit:
- Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening AlgorithmClinical Gastroenterology and Hepatology, 2016
- The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen ResourceReviews on Recent Clinical Trials, 2015
- Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold RuleJournal of Clinical Oncology, 2013
- Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screeningOncology Letters, 2012
- Pulmonary Nodules: Growth Rate Assessment in Patients by Using Serial CT and Three-dimensional VolumetryRadiology, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- Estimation and Comparison of Receiver Operating Characteristic CurvesThe Stata Journal: Promoting communications on statistics and Stata, 2009
- A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarkerBiostatistics, 2003
- Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000